173 related articles for article (PubMed ID: 15659299)
1. Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.
Dableh LJ; Yashpal K; Rochford J; Henry JL
Eur J Pharmacol; 2005 Jan; 507(1-3):99-105. PubMed ID: 15659299
[TBL] [Abstract][Full Text] [Related]
2. Effect of tachykinin receptor antagonists in experimental neuropathic pain.
Coudoré-Civiale MA; Courteix C; Eschalier A; Fialip J
Eur J Pharmacol; 1998 Nov; 361(2-3):175-84. PubMed ID: 9865506
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
4. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response.
McLean PG; Garcia-Villar R; Fioramonti J; Buéno L
Eur J Pharmacol; 1998 Mar; 345(3):247-52. PubMed ID: 9592022
[TBL] [Abstract][Full Text] [Related]
5. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle.
Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L
Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089
[TBL] [Abstract][Full Text] [Related]
6. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
7. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of non-peptidic tachykinin receptor antagonists on Ca2+ channels.
Lombet A; Spedding M
Eur J Pharmacol; 1994 Mar; 267(1):113-5. PubMed ID: 8206125
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
[TBL] [Abstract][Full Text] [Related]
10. The potency of the novel tachykinin receptor antagonist CGP49823 at rat and gerbil motoneurones in vitro.
Pozza MF; Olpe HR; Ofner S; Schoeffel C; Evans RH
Eur J Pharmacol; 1998 Jan; 342(2-3):203-8. PubMed ID: 9548386
[TBL] [Abstract][Full Text] [Related]
11. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
12. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
13. Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat.
Lam FY; Wong MC
Br J Pharmacol; 1996 Aug; 118(8):2107-14. PubMed ID: 8864549
[TBL] [Abstract][Full Text] [Related]
14. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
15. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine and tachykinin receptor antagonists attenuate wood smoke-induced bronchoconstriction in guinea pigs.
Hsu TH; Lai YL; Kou YR
Eur J Pharmacol; 1998 Nov; 360(2-3):175-83. PubMed ID: 9851584
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists.
Wallace-Boone TL; Newton AE; Wright RN; Lodge NJ; McElroy JF
Neuropsychopharmacology; 2008 Jul; 33(8):1919-28. PubMed ID: 17912250
[TBL] [Abstract][Full Text] [Related]
18. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic characterization of receptor types mediating coronary vasodilator actions of sensory neuropeptides in the guinea pig.
Lam FF
J Cardiovasc Pharmacol; 2000 Apr; 35(4):646-52. PubMed ID: 10774797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
